AstraZeneca looks to spin-offs to focus portfolio

AstraZeneca’s chief executive Pascal Soriot outlined plans to offload or find partners for the group’s infection and neuroscience arms that together generate sales of US$3.5bn at the company’s AGM yesterday,…